<DOC>
	<DOCNO>NCT00156637</DOCNO>
	<brief_summary>The goal project translate research finding key aspect antipsychotic treatment routine care multi-component intervention , focus improve two aspect medication management directly link patient outcome : 1 ) monitoring potentially serious metabolic side effect newer antipsychotic medication , 2 ) increase appropriate use clozapine treatment-refractory patient .</brief_summary>
	<brief_title>A Study Strategies Improve Schizophrenia Treatment</brief_title>
	<detailed_description>Background : Antipsychotic medication far widely utilized treatment schizophrenia VA setting , VA establish guideline appropriate use medication . The recent introduction new generation antipsychotic medication also offer great hope person schizophrenia , also may adversely affect health due metabolic side effect . Improving aspect antipsychotic medication management necessary improve outcome person schizophrenia . Objectives : The goal project translate research finding key aspect antipsychotic treatment routine care multi-component intervention . Mental Health QUERI 's ( MHQ ) previous project improve antipsychotic treatment demonstrate multi-component intervention improve use guideline-recommended antipsychotic dos . This project build result lesson learn MHQ 's previous translation project . The scope translation expand ongoing focus reduce high antipsychotic dos include two additional aspect medication management directly link patient outcome : 1 ) increase monitor potentially serious side effect newer antipsychotic medication , 2 ) increase appropriate use clozapine treatment-refractory patient . Methods : The project employ multi-component intervention improve antipsychotic prescribe compare use two different interpersonal marketing/influence strategy translation . The primary objective compare effectiveness team-based QI approach strategy use clinical opinion leader augment implementation coordinator improve antipsychotic medication management . In addition , MHQ determine impact support consultation program promote clozapine prescribing . A total ten VA Medical Centers 4 different VA health care network ( VISNs ) select participate basis number patient schizophrenia , baseline performance quality indicator , organizational characteristic . Six sit focus side effect monitoring antipsychotic dosing ( two team-based QI , two clinical opinion leader , two control ) , two receive clozapine consultation program , two match control site . Selected clinicians staff ( opinion leader ) identify train , implement multi-component intervention consist educational material program , information system tool , performance monitoring feedback . The intervention take place 6 month , assess regard improvement side effect monitoring , high dose antipsychotic prescribing , clozapine use . In addition , MHQ assess impact intervention patient outcomes five site . Status : In partnership clinical stakeholder , project team implementing , adapt evaluate assortment clinical tool train material design improve antipsychotic medication management . All , site , except 1 , complete intervention . All subject recruitment complete . The project team also work participate VAMC IT staff Clinical Coordinators fully automate project 's VISTA data extraction reoutines performance monitoring reporting system local implmentation maintainence</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<criteria>SITE : 300 patient schizophrenia diagnosis Below national VA average high antipsychotic dosing ( dose site ) use clozapine ( clozapine site ) ? Site leader buyin PATIENT : Clinical diagnosis schizophrenia schizoaffective disorder 1865 year age Had least 1 inpatient stay outpatient visit facility past year [ Dosing Sites ] Filled antipsychotic prescription dose exceeds guideline recommendation past 3 month [ Clozapine Sites ] Scores positive computer routine identify potential candidate trial clozapine SITE : No affiliation Institutional Review Board Research Development office protocol review/approval PATIENT : No access telephone Enrolled conflicting study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>quality health care</keyword>
	<keyword>quality indicator</keyword>
	<keyword>intervention study</keyword>
</DOC>